GLP1R and diabetic kidney disease: 6. A Four-Pillared Therapeutic Strategy in Diabetic Kidney Disease: Integrating RAS Blockade, SGLT2 Inhibitors, GLP-1 RAs, and ns-MRAs for Optimal Cardiorenal Protection